Article

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220.

Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA.
Vaccine (Impact Factor: 3.49). 08/2010; 28(34):5597-604. DOI: 10.1016/j.vaccine.2010.06.030
Source: PubMed

ABSTRACT HIV-infected persons are at risk for HBV co-infection which is associated with increased morbidity and mortality. Unfortunately, protective immunity following HBV vaccination in HIV-infected persons is poor. This randomized, phase II, open-label study aimed to evaluate efficacy and safety of 40 mcg HBV vaccine with or without 250 mcg GM-CSF administered at day 0, weeks 4 and 12. HIV-infected individuals >or=18 years of age, CD4 count >or=200 cells/mm(3), seronegative for HBV and HCV, and naïve to HBV vaccination were eligible. Primary endpoints were quantitative HBsAb titers and adverse events. The study enrolled 48 subjects. Median age and baseline CD4 were 41 years and 446 cells/mm(3), 37 were on ART, and 26 subjects had undetectable VL. Vaccination was well tolerated. Seven subjects in the GM-CSF arm reported transient grade >or=2 signs/symptoms (six grade 2, one grade 3), mostly aches and nausea. GM-CSF had no significant effect on VL or CD4. Four weeks after vaccination, 26 subjects (59%) developed a protective antibody response (HBsAb >or=10 mIU/mL; 52% in the GM-CSF arm and 65% in the control arm) without improved Ab titer in the GM-CSF vs. control arm (median 11 mIU/mL vs. 92 mIU/mL, respectively). Response was more frequent in those with CD4 >or=350 cells/mm(3) (64%) than with CD4 <350 cells/mm(3) (50%), though not statistically significant. GM-CSF as an adjuvant did not improve the Ab titer or the development of protective immunity to HBV vaccination in those receiving an accelerated vaccine schedule. Given the common routes of transmission for HIV and HBV, additional HBV vaccine research is warranted.

Full-text

Available from: Debra DeMarco Shaw, May 30, 2015
0 Followers
 · 
80 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis B vaccine has been recommended for use in people living with HIV (PLHIV) mostly because of the similarities in routes of infection and their prevalence in the same geographic areas. PLHIV may not develop sero-protection after receiving standard hepatitis B vaccine due to their compromised immune status.
    Cochrane database of systematic reviews (Online) 10/2014; 10(10):CD009886. DOI:10.1002/14651858.CD009886.pub2 · 5.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis B virus (HBV) infection is a leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma worldwide. Due to the shared modes of transmission, coinfection with HBV and human immunodeficiency virus (HIV) is not uncommon. It is estimated that 10% of HIV-infected patients worldwide are coinfected with HBV. In areas where an HBV vaccination program is implemented, the HBV seroprevalence has declined significantly. In HIV/HBV-coinfected patients, HBV coinfection accelerates immunologic and clinical progression of HIV infection and increases the risk of hepatotoxicity when combination antiretroviral therapy (cART) is initiated, while HIV infection increases the risk of hepatitis events, cirrhosis, and end-stage liver disease related to chronic HBV infection. With the advances in antiviral therapy, concurrent, successful long-term suppression of HIV and HBV replication can be achieved in the cART era. To reduce the disease burden of HBV infection among HIV-infected patients, adoption of safe sex practices, avoidance of sharing needles and diluent, HBV vaccination and use of cART containing tenofovir disoproxil fumarate plus emtricitabine or lamivudine are the most effective approaches. However, due to HIV-related immunosuppression, using increased doses of HBV vaccine and novel approaches to HBV vaccination are needed to improve the immunogenicity of HBV vaccine among HIV-infected patients.
    World Journal of Gastroenterology 10/2014; 20(40):14598-14614. DOI:10.3748/wjg.v20.i40.14598 · 2.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Stalagmite ZJD-21 (12.3-cm long) was collected from Zhijin Cave in Zhijin County, Guizhou, China. Its 210Pb profile and seven 230Th/234U dates indicate that the stalagmite has grown continuously for the past 1100years. The δ18O record of ZJD-21 indicates that δ18O in the stalagmite was mainly influenced by rainfall amount and/or summer/winter rain ratio, with lighter values corresponding to wetter climatic conditions and/or more summer monsoonal rains. The ZJD-21 δ18O record suggests: (1) dry/warm climates during AD 950-1100 (overlapping with most of the Medieval Warm Period, MWP, in Europe); (2) strengthening of the summer monsoon from the MWP toward the beginning of the Little Ice Age (LIA) at AD 1250; (3) relatively wet/cold conditions occurred between AD 1250 and 1500, shown by relatively light δ18O values; (4) the summer monsoon intensity strongly declined referred by the increase δ18O trend from AD 1500 to AD 1600, perhaps resulting in dry/cold conditions; and (5) a strongly enhancement of the summer monsoon intensity appeared from AD 1700 to 1950, reflecting wet/cold conditions during the late period of the LIA. On decadal scales the monsoonal climate of central western Guizhou can be either warm/wet and cold/dry, or warm/dry and cold/wet. The δ13C variations in ZJD-21 on decadal-to-centennial scales respond mainly to vegetation changes with heavier values reflecting lesser amount of forest coverage. Prior to AD 1700, the δ13C generally co-varied with δ18O reflecting the expected more extensive vegetation growth (lighter δ13C) under wetter climate (lighter δ18O). However, during the past 300years the δ13C increased sharply showing an opposite trend to that of δ18O. This observation strongly suggests that a decline of surface vegetation due to an artificial deforestation might have occurred – an occurrence coincident with the large-scale immigration into central western Guizhou in connection with copper-mining activities during the reign of Emperor Yongzheng of Qing Dynasty. Since the late 1890s, especially in the past 50years, population surge has led to serious karst rocky desertification in the area.
    Journal of Asian Earth Sciences 04/2011; 40(6):1111-1120. DOI:10.1016/j.jseaes.2011.01.001 · 2.83 Impact Factor